If you are newly diagnosed with Hodgkin lymphoma, the diagnosis can become overwhelming. Dr. Burke breaks down questions to discuss with your doctor and gives resource info.
Published:
What is a co-pay accumulator, and how will it affect cancer patients access to treatment? Noted healthcare attorney Stacey Worthy discusses what patients need to know about the “double-dip” insurance deductible.
Published:
Expert Dr. John Burke discusses what’s new in the world of Hodgkin lymphoma. Watch now to learn about new studies on the use of radiation, how to treat early stage patients, and more.
Published:
An audience of Hodgkin lymphoma patients and their care partners joined us online as Hodgkin lymphoma expert Dr. John Burke of Rocky Mountain Cancer Centers answered audience questions.
Published:
Dr. John Burke speaks with Lee Swanson about new and improving therapies for Hodgkin lymphoma from ASH 2018.
Published:
Dr. Ramchandren joins Lee Swanson to discuss the changing treatment for Hodgkin lymphoma patients. From management of side effects to new line treatments, they discuss how patients can best discuss these changes with their doctors.
Published:
On location in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.
Published:
Is diversity, gender, age and ethnicity important in clinical trials? Mel Mann, a 20+ year CML survivor and a a highly respected leader in the field of clinical oncology weigh in.
Published:
A common question patients have when considering a clinical trial is “will I be a guinea pig?” Meet Reina Weiner, a four-time clinical trial participant, as she shares her experience navigating the trial process, patient consent, safety, risks, family issues and more.
Published:
